WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Its officially classified as an antioxidant, but our cells use it for the production of adenosine triphosphate (ATP), which helps give cells energy and vitality for healthy growth and maintenance
Anti-cancer effects of torulene, isolated from Sporidiobolus pararoseus , on human prostate cancer LNCaP and PC-3 cells via a mitochondrial signal pathway and the down-regulation of AR expression
These are for your convenience so that you do not have to fill in your details again when you leave another comment
In a recent survey, 18% of adults said they had used GLP-1 drugs for weight loss or to treat diabetes or other chronic conditions, while 12% said they were currently using them
